mDR Ltd - Dec 16, 2024 SCHEDULE 13G/A Report for CytoMed Therapeutics Ltd Ordinary Shares, no par value per share (GDTC)

Filing Manager: mDR Ltd
Reporting Manager: mDR LTD
Security: CytoMed Therapeutics Ltd Ordinary Shares, no par value per share
Symbol: GDTC
Shares outstanding: 11.5M shares
Disclosed Ownership: 1.31M shares
Ownership: 11.3%
Form type: SCHEDULE 13G/A
Date filed: 3/24/2025, 12:01 PM
Date of event: Dec 16, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
mDR LTD	11.33%	1.31M	1.31M	0	/s/ Edward Lee Ewe Ming	Executive Chairman

Showing 1 to 1 of 1 entries